Cumberland Pharmaceuticals Inc.
CPIX
$4.76
$0.235.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.48M | -10.87M | -10.38M | -8.42M | -6.28M |
| Total Depreciation and Amortization | 6.04M | 5.62M | 5.71M | 5.78M | 5.77M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.47M | 2.01M | 2.02M | 3.81M | 1.97M |
| Change in Net Operating Assets | 1.29M | 1.77M | 1.94M | 4.21M | 4.63M |
| Cash from Operations | -612.20K | -1.48M | -715.70K | 5.38M | 6.09M |
| Capital Expenditure | -66.50K | -112.90K | -150.60K | -215.60K | -281.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.30K | 458.10K | 211.20K | 226.20K | 175.60K |
| Cash from Investing | 57.80K | 345.20K | 60.50K | 10.50K | -105.80K |
| Total Debt Issued | 38.49M | 40.69M | 37.48M | 34.48M | 31.48M |
| Total Debt Repaid | -36.00M | -37.52M | -34.53M | -34.46M | -34.89M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -579.00K | -669.60K | -772.50K | -801.10K | -740.60K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.72M | -2.41M | -2.43M | -2.43M | -3.27M |
| Cash from Financing | 196.90K | 88.20K | -257.60K | -3.22M | -7.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -357.40K | -1.04M | -912.50K | 2.16M | -1.44M |